Status:
COMPLETED
Clinical Study of Biokinetic Model of Iodine-131 in Total(Near) Thyroidectomy Patients.
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Thyroidectomy
Eligibility:
All Genders
20+ years
Brief Summary
Thyroid cancer patients who have undergone total thyroidectomy, postoperative iodine 131 treatment to ablation residual thyroid tissue, is the current clinical practice. The effective half-life of the...
Detailed Description
Methods Patients:All patients undergoing thyroidectomy and are about to be treated with iodine 131 30mCi will be invited to join the study. Exclusion with gastrointestinal surgery. Preparation:The pa...
Eligibility Criteria
Inclusion
- All patients undergoing thyroidectomy and are about to be treated with iodine 131 30mCi will be invited to join the study.
Exclusion
- Exclusion with gastrointestinal surgery.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03349294
Start Date
November 1 2017
End Date
December 31 2019
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
New Taipei City, Taiwan, 220